A phase I study of combination immunotherapy with five peptides cocktail, CpG, and immune modulators for patients with advanced or metastatic colorectal cancer
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
Interventions: combination immunotherapy Primary outcome(s): safety Study Design: Single arm Non-randomized
创建时间：
2016-04-15
